We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MIVI Neuroscience Gets Form 483 for CAPA, Complaint Issues
MIVI Neuroscience Gets Form 483 for CAPA, Complaint Issues
MIVI Neuroscience received a Form 483 with three observations for inadequate corrective and preventive action (CAPA) activities and documentation issues observed during an FDA inspection of the company’s facility in Eden Prairie, Minn., last December.